- Home
- KYMR vs CENX Comparison
KYMR vs CENX Comparison
Compare KYMR & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | CENX |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Aluminum |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.1B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | KYMR | CENX |
|---|---|---|
| Price | $97.66 | $47.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 26 | 3 |
| Target Price | ★ $107.72 | $65.67 |
| AVG Volume (30 Days) | 738.5K | ★ 2.1M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.23 |
| Revenue | $39,211,000.00 | ★ $1,893,200,000.00 |
| Revenue This Year | $10.61 | $20.77 |
| Revenue Next Year | $8.17 | $14.58 |
| P/E Ratio | ★ N/A | $15.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.88 | $17.22 |
| 52 Week High | $105.00 | $70.43 |
Technical Indicators
Market Signals| Indicator | KYMR | CENX |
|---|---|---|
| Relative Strength Index (RSI) | 72.22 | 30.48 |
| Support Level | $76.40 | $45.49 |
| Resistance Level | $103.00 | $51.08 |
| Average True Range (ATR) | 4.71 | 3.47 |
| MACD | 2.41 | -1.71 |
| Stochastic Oscillator | 79.56 | 2.94 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.